Genetic Therapy Accelerator Centre
The Centre combines laboratory and clinical expertise focused on neurological disorders, their mechanisms of disease and RNA and AAV gene therapy expertise. The Centre facilitates cutting-edge RNA and gene therapy programs to pursue discovery of novel therapies using RNA and AAV technologies, with identification and refinement of target for therapeutic intervention.
The centre is based at ION QS, and subsequently will be at the new £281m Translational Neuroscience building on Grays Inn Road in 2025. It will combine laboratory and clinical expertise focused on neurological, neuromuscular and neurodegenerative disorders, their mechanisms of disease and cutting-edge RNA and AAV gene therapy expertise and foster cross-institutional collaborations between ION QS and GOSH ICH.
For more than three decades, UCL has worked at the frontiers of brain science: making fundamental discoveries about brain function and behaviour, transforming our ability to treat neurological and psychiatric disorders, and training the next generation of scientists and clinicians. With the visionary support of funders, we are set to achieve a neuroscience revolution which will improve the lives of millions.